- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2012-004458-27. Displaying page 1 of 1.
|EudraCT Number: 2012-004458-27||Sponsor Protocol Number: GS-US-292-0104||Start Date*: 2013-05-13|
|Sponsor Name:Gilead Sciences Inc.|
|Full Title: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir D...|
|Medical condition: Human Immunodeficiency Virus (HIV-1) Infection|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: BE (Completed) AT (Completed) IT (Ongoing) SE (Completed) NL (Prematurely Ended) GB (Ongoing) DE (Completed) PT (Completed) ES (Completed)|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.